Memo
Now recognised as the largest and most established European orphan drug event, we are once again proud to deliver another outstanding speaker line-up and a content-filled agenda that represents the whole orphan drug landscape. The 10th annual event will address the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases.
For 2019 we will be expanding the meeting further with a dedicated co-conference on Cell & Gene Therapy and even more dedicated content and tracks than ever before on Clinical/Product Development, Market Access & Pricing, Manufacture, Science & Strategy, Pitch & Partner and Precision Medicine. We will also continue the highly popular Pre-Congress Workshops.
We thank our Advisory Board members for their contribution to the agenda in 2018 - and look forward to working together to make 2019 even more successful.
Tickets https://go.evvnt.com/480041-0?pid=5569
Prices:Conference & Workshops EUR 3570.00Conference Only EUR 3070.00Conference & Workshops - Academic or Regulatory EUR 2030.00Conference Only - Academic or Regulatory EUR 1590.00
Speakers: Andrzej Rys, Kristina Larsson, Bernard J. Grimm, Delphine Roulland, Ulrika Vestin, Prof Maurizio Scarpa, Anne Pariser, Dr Vinciane Pirard, Mark Rothera, Stuart Peltz, Bob Smith, Sander van Deventer, Frederic Chereau, Marcus Guardian
Time: on Tuesday November 12, 2019 at 8:30 am (ends Thursday November 14, 2019 at 6:30 pm)